Promoter methylation status of ASC/TMS1/PYCARD is associated with decreased overall survival and TNM status in patients with early stage non-small cell lung cancer (NSCLC)

BACKGROUND: Lung cancer is the leading cause of cancer-related death worldwide, with 5-year overall survival less than 15%. Therefore, it is essential to find biomarkers for early detection and prognosis. Aberrant DNA methylation is a common feature of human cancers and its utility is already recogn...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transl Lung Cancer Res
Autori principali: Šutić, Maja, Motzek, Antje, Bubanović, Gordana, Linke, Matthias, Sabol, Ivan, Vugrek, Oliver, Ozretić, Petar, Brčić, Luka, Seiwerth, Sven, Debeljak, Željko, Jakovčević, Antonija, Janevski, Zoran, Stančić-Rokotov, Dinko, Vukić-Dugac, Andrea, Jakopović, Marko, Samaržija, Miroslav, Zechner, Ulrich, Knežević, Jelena
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6976376/
https://ncbi.nlm.nih.gov/pubmed/32010578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.12.08
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi